| Pharmaceutical active ingredients: |
| Ethoxzolamide |
| Available forms, composition and doses of Cardrase: |
| Tablets; Oral; Ethoxzolamide 125 mgTablets; Oral; Ethoxzolamide 62.5 mg |
| Cardrase medical category: |
| Human:Carbonic anhydrase inhibitorsSulfonamide medications |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pfizer |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nocrack AW | Ethoxyquin | Unidentified Pharmaceutical Company |
| Quinol ED | Ethoxyquin | Unidentified Pharmaceutical Company |
| Santoquin | Ethoxyquin | Unidentified Pharmaceutical Company |
| Santoquine | Ethoxyquin | Unidentified Pharmaceutical Company |
| Stop-Scald | Ethoxyquin | Unidentified Pharmaceutical Company |
| Diuretic C | Ethoxzolamide | Unidentified Pharmaceutical Company |
| Ethamide | Ethoxzolamide | Allergan |
| Mingoral | Ethoxzolamide | Unidentified Pharmaceutical Company |
| Redupresin | Ethoxzolamide | Unidentified Pharmaceutical Company |
| Epiglu | Ethyl 2-Cyanoacrylate; Polymethylmethacrylate | Valeant Pharmaceuticals; Meyer-Haake Medical Innovations; Synapse Medical |